Example searches

WAT Waters Corp

All WAT filings Filing statistics SEC
Waters Corp. is a measurement company, which engages in the analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through Waters and TA segments. The Waters segment designs, manufactures, distributes and services liquid chromatography and ultra performance liquid chromatography instruments, columns and other chemistry consumables that can be integrated and used along with other analytical instruments. The TA Instruments segment designs, manufactures, distributes and services thermal analysis, rheometry and calorimetry instruments. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.

Company profile

Ticker
WAT
Exchange
NYSE
Website
www.waters.com
CEO
Christopher James O'Connell
Employees
Incorporated in
Delaware
Location
Massachusetts
Fiscal year end
Dec 31
Sector
Health Technology > Medical Specialties
Industry (SEC)
Laboratory Analytical Instruments
Avantor • Bio-Rad Laboratories • Illumina • Bruker • Agilent • Perkinelmer • Coherent • Mettler-Toledo International • Fluidigm • Harvard Bioscience ...
SEC CIK
0001000697
Corporate docs
IRS number
133668640

WAT stock data

(
)

Calendar

30 Oct 19
20 Jan 20
31 Dec 20

News

Company financial data Financial data

Chart WAT financial data
Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 577.28M 599.16M 513.86M 715.02M
Net income 138.13M 144.41M 108.99M 185.15M
Diluted EPS 2.07 2.08 1.51 2.46
Net profit margin 23.93% 24.10% 21.21% 25.89%
Operating income 173.24M 177.65M 121.15M 244.53M
Net change in cash -183.35M -96.97M -111.31M
Cash on hand 404.65M 588M 684.97M 796.28M
Cost of revenue 286.87M
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 2.42B 2.31B 2.17B 2.04B
Net income 593.79M 20.31M 521.5M 469.05M
Diluted EPS 7.65 0.25 6.41 5.65
Net profit margin 24.54% 0.88% 24.06% 22.97%
Operating income 739.77M 662.2M 625.04M 567.45M
Net change in cash 153.96M 136.69M 17.97M 65.49M
Cash on hand 796.28M 642.32M 505.63M 487.67M
Cost of revenue 992.56M 947.07M 891.45M 842.67M

Financial data from Waters earnings reports

Institutional ownership Q3 2019

WAT institutional ownership history Ownership history
13F holders
 Current Prev Q Change
Total holders 567 573 -1.0%
Opened positions 44 48 -8.3%
Closed positions 50 69 -27.5%
Increased positions 160 177 -9.6%
Reduced positions 236 241 -2.1%
13F shares
 Current Prev Q Change
Total value 223.32B 177.24B +26.0%
Total shares 62.43M 63.38M -1.5%
Total puts 137.94K 69.23K +99.2%
Total calls 133.93K 295.69K -54.7%
Total put/call ratio 1.0 0.2 +339.9%
Largest owners
 Shares Value Change
Vanguard 7.33M $1.64B -3.7%
Massachusetts Financial Services 5.57M $1.24B +18.1%
BLK BlackRock 5.33M $1.19B -0.5%
Fundsmith 5.12M $1.14B +0.2%
BK Bank Of New York Mellon 4.56M $1.02B +7.4%
STT State Street 3.01M $671.01M -3.5%
Baillie Gifford & Co 2.46M $548.56M -1.8%
JHG Janus Henderson 1.64M $366.36M -3.5%
Champlain Investment Partners 983.22K $219.48M +10.2%
Geode Capital Management 980.33K $218.58M -14.5%
Largest transactions
 Shares Bought/sold Change
Massachusetts Financial Services 5.57M +854K +18.1%
Renaissance Technologies 80.1K -397.83K -83.2%
Frontier Capital Management 0 -317.14K EXIT
BK Bank Of New York Mellon 4.56M +313.67K +7.4%
Bessemer 2.43K -312.22K -99.2%
Vanguard 7.33M -282.97K -3.7%
Mitsubishi UFJ Trust & Banking 589.95K +262.91K +80.4%
CBAUF Commonwealth Bank Of Australia 0 -254.39K EXIT
Select Equity 432.16K +201.82K +87.6%
Ajo 32.36K -191.58K -85.5%
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Perkinelmer • General Electric • Thermo Fisher Scientific • Danaher • Dionex • Danaher • Merck Kgaa • Mettler-Toledo International • Varian • Agilent
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Brazil, crease, creased, eniorunsecured, expensein, favorable, illion, Interactive, iXBRL, large, low, Mexico, millionand, millionexpense, notice, optimal, Page, rateswe, slightly, softer, Thede, thefourth, thenote, theTax, Thisincrease, Western, written
Removed: final, gain, resolved, verdict, XBRL
From filing 10-Q 2019 Q3

Financial reports

View all
10-Q
2019 Q3
Quarterly report
30 Oct 19
10-Q
2019 Q2
Quarterly report
31 Jul 19
10-Q
2019 Q1
Quarterly report
3 May 19
10-K/A
2018 FY
Annual report (amended)
1 Mar 19
10-K
2018 FY
Annual report
26 Feb 19
10-Q
2018 Q3
Quarterly report
2 Nov 18
10-Q
2018 Q2
Quarterly report
3 Aug 18
10-Q
2018 Q1
Quarterly report
4 May 18
10-K
2017 FY
Annual report
27 Feb 18
10-Q
2017 Q3
Quarterly report
3 Nov 17

Current reports

View all
8-K
Results of Operations and Financial Condition
29 Oct 19
8-K
Entry into a Material Definitive Agreement
16 Sep 19
8-K
Strong pharmaceutical growth, partially offset by softness in industrial
30 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
16 May 19
8-K
Results of Operations and Financial Condition
23 Apr 19
8-K
Full Year 2018 Financial Results
23 Jan 19
8-K
Salesof $578 million grew 2% as reported and 3% in constant currency
23 Oct 18
8-K
Departure of Directors or Certain Officers
6 Sep 18
8-K
Salesof $596 million grew 7% as reported and 5% in constant currency
24 Jul 18
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
15 May 18

Registration and prospectus

View all
15-12B
Securities registration termination
24 Apr 13
25-NSE
Exchange delisting
9 Apr 13
S-8
Registration of securities for employees
5 Sep 12
S-8
Registration of securities for employees
10 Jul 09
S-8
Registration of securities for employees
13 Oct 06
S-3ASR
Automatic shelf registration
26 May 06
S-8
Registration of securities for employees
20 Nov 03
8-A12B/A
Registration of securities on exchange (amended)
27 Aug 02
S-8
Registration of securities for employees
12 Jul 02
S-8
Registration of securities for employees
2 May 01

Proxies

View all
DEFA14A
Additional proxy soliciting materials
4 Apr 19
DEF 14A
Definitive proxy
4 Apr 19
DEF 14A
Definitive proxy
29 Mar 18
DEFA14A
Additional proxy soliciting materials
29 Mar 18
DEF 14A
Definitive proxy
29 Mar 17
DEFA14A
Additional proxy soliciting materials
29 Mar 17
PX14A6G
Letter to shareholders
29 Mar 17
DEF 14A
Definitive proxy
1 Apr 16
DEFA14A
Additional proxy soliciting materials
1 Apr 16
DEF 14A
Definitive proxy
1 Apr 15

Other

View all
SD
Conflict minerals disclosure
8 May 19
SD
Conflict minerals disclosure
2 May 18
SD
Conflict minerals disclosure
25 May 17
UPLOAD
Letter from SEC
28 Jun 16
CORRESP
Correspondence with SEC
27 Jun 16
UPLOAD
Letter from SEC
17 Jun 16
CORRESP
Correspondence with SEC
1 Jun 16
SD
Conflict minerals disclosure
25 May 16
UPLOAD
Letter from SEC
24 May 16
CORRESP
Correspondence with SEC
5 May 16

Ownership

View all
SC 13G/A
Waters Corp /De/
13 Feb 19
SC 13G/A
Waters Corp /De/
11 Feb 19
SC 13G/A
Waters Corp /De/
6 Feb 19
SC 13G
Waters Corp /De/
4 Feb 19
SC 13G/A
Waters Corp /De/
10 Apr 18
SC 13G
Waters Corp /De/
14 Feb 18
SC 13G/A
Waters Corp /De/
9 Feb 18
SC 13G/A
Waters Corp /De/
9 Feb 18
SC 13G/A
Waters Corp /De/
23 Jan 18
SC 13G/A
Waters Corp /De/
14 Feb 17